Skip to content

NP-Supported Multidisciplinary Diabetes Management During Perioperative Period

NP-Supported Multidisciplinary Diabetes Management During Perioperative Period in Patient With Diabetes Mellitus

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05293015
Acronym
NPMDM-PP
Enrollment
170
Registered
2022-03-23
Start date
2022-04-01
Completion date
2023-03-31
Last updated
2022-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Keywords

nurse practitioners, Multidisciplinary Diabetes Management, perioperative period

Brief summary

The primary objective of this study is to determine the benefits of interventions from a Multidisciplinary Diabetes Care team involved of diabetes nurse practitioners(DNP) on glucose control, perioperative outcomes and psychosocial outcomes for patients with Diabetes Mellitus

Detailed description

About 50% of diabetic patients will undergo at least one surgical operation, and nearly 20% of surgical patients have diabetes.Compared with non-diabetic patients, diabetic patients face greater risks during the perioperative period. Stress factors such as preoperative preparation, anesthesia, surgical trauma, pain, drugs and negative emotions can induce blood glucose fluctuations, which could lead to complications such as hyperglycemia, diabetic ketosis, and hypoglycemia.Therefore, perioperative management has become an important part of diabetes management. A multidisciplinary collaborative team led by NP can reduce the mortality of patients after inpatient surgery, help patients change their lifestyle, maintain self-management behavior, improve patient experience, and reduce hospitalization costs. This study intends to explore the application effect of NP-led multidisciplinary collaborative team in the perioperative comprehensive management of diabetic patients.

Interventions

OTHERNP-Supported Multidisciplinary Diabetes Management

NP establishes files to evaluate and manage patients before hospital and visits patients after hospitalization. Then set blood glucose control goals with endocrinology and orthopedic doctors together, initiates consultation with endocrinologists for patients with postoperative hyperglycemia, and is responsible for post-hospital follow-up.

Sponsors

Roche Pharma AG
CollaboratorINDUSTRY
Peking University Third Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis meets World Health Organization (WHO) (1999) Diabetes Diagnostic Standards * Orthopedic assessment requires elective surgery and no surgical contraindications * HbA1c≥8.5% or intravenous fasting blood glucose (FBG)\>10mmol/l * Informed consent.

Exclusion criteria

* Cognitive and communication disorders; * Pregnancy; * Participate in other intervention studies.

Design outcomes

Primary

MeasureTime frameDescription
EFFICACY: TIR(Time in Range)From into the group to the first hospital day; First day in hospital to the day of dischargeTime in range

Secondary

MeasureTime frameDescription
EFFICACY: Incidence of perioperative hypoglycemiaFrom into the grop to 1 month after surgery. And confirmed based on the patient's main complaint and monitoring records.Incidence of perioperative hypoglycemia would be conducted to measure glucose control
EFFICACY: Time required for blood glucose standard before surgerythe first hospital dayThe time from the patient's enrollment to the blood glucose reaching the blood glucose control target
EFFICACY: Diabetes self-management behaviorMeasurements were taken at baseline, day of hospitalization, and 1 month after dischargemeasured by Summary of Diabetes Self-Care Activities(SDSCA). SDSCA scores from 0 to 77 and higher score means better self-management behaviors.
EFFICACY: Incidence of perioperative adverse events1 month after dischargeAdverse events included wound infection, prolonged wound healing time, and death within 1 month after surgery.
EFFICACY: Glycated Serum Proteinbaseline and 1 month after dischargedGlycated Serum Protein would be conducted to measure glucose control
EFFICACY: Body weightbaseline, day of hospitalization, during hospitalization and 1 month after dischargeThe same scale was used to measure after patients got up in the morning.
EFFICACY: Anxiety and depressionMeasurements were taken at baseline, day of hospitalization, and 1 month after dischargemeasured by Hospital Anxiety and Depression Scale (HADS) scale. HADS contains two subscales: anxiety and depression, and each subscale have 7 items. Total scores were from 0 to 42(anxiety: 21 scores; depression: 21 scores), higher score means more severe anxiety and/or depression.
QUALITY OF LIFE:living qualityMeasurements were taken at baseline, day of hospitalization, and 1 month after dischargemeasured by Short Form 36 Health Survey (SF-36) which contains 8 modules with different score formula. Higher total scores mean better living quality.
EFFICACY: Blood pressurebaseline, day of hospitalization, during hospitalization and 1 month after dischargeA calibrated electronic blood pressure meter of the same brand was used to measure systolic pressure and diastolic pressure in the same arm at the same time daily

Contacts

Primary ContactQun Wang
wq3025@sina.com13901280942

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026